Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

A High-Throughput Drug Repurposing Strategy to Treat TBX2 and/or TBX3 Dependent Cancers.

Bleloch JS. et al, (2024), Cancer Med, 13

Nucleoside supplements as treatments for mitochondrial DNA depletion syndrome.

Dombi E. et al, (2024), Front Cell Dev Biol, 12

Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models.

Rodriguez-Berriguete G. et al, (2023), Clin Cancer Res, 29, 1631 - 1642

Include forthcoming?